Latest news with #EDITH
Daily Mirror
07-05-2025
- Entertainment
- Daily Mirror
Ignore streaming on Spotify, the cassette player returns and is way better than before
The cassette is making a comeback. Vinyl has already seen a massive resurgence in recent years; now it appears that the humble cassette player is making a surprise comeback. Anyone who lived through the 80s and 90s will surely remember getting a Sony Walkman, which offered one of the first ever ways to take music on the move. It launched all the way back in 1979 and became an instant hit, with over 400 million sold worldwide. Sony retired its cassette-style Walkman in 2010 (they still make digital players with the same name), but it seems the legend lives on. Now, before retro audio fans start getting too excited, the return of the portable tape player isn't part of Sony's grand plans. Instead, the team We Are Rewind are bringing a new cassette player to pockets with the launch of the EDITH WE-001, and it adds plenty of modern twists to this ageing technology. This new music player arrives with full Bluetooth connectivity. That means you can link up your wireless headphones or beam those classic tunes to portable speakers. There are physical buttons on the case let you play, fast forward and rewind, plus there's even the option to record things straight onto tapes you have in the player. A premium design with Aluminium casing is included rather than old style plastic and the firm is promising decent battery life for those long journeys. Another bonus is that the EDITH WE-001 doesn't rely on annoying AA batteries with it featuring a fully rechargeable power pack instead. EDITH is out now and costs £129. We Are Rewind products can be picked up shops including at Rough Trade, Selfridges, FNAC, Turntable Lab and many independent record stores.
Yahoo
04-02-2025
- Health
- Yahoo
UK launches AI EDITH trial to catch breast cancer earlier
Nearly 70,000 women throughout the UK are set to take part in an AI-driven trial designed to advance methods of early breast cancer detection backed by £11m in government funding. Announced on World Cancer Day on 4 February, the Early Detection using Information Technology in Health (EDITH) trial will see 30 testing sites across the country equipped with AI technology and medical devices. In its announcement, the UK's Department for Health and Social Care (DHSC) described how two specialists are currently required to carry out a typical mammogram. The EDITH trial aims to reduce the number of medical staff required to carry out a mammogram screening to one. New targets for the UK's National Health Service (NHS) for 2025 call for the body to ensure that four out of five patients receive a diagnosis or be given the all-clear within 28 days of a cancer referral. NIHR CEO Lucy Chappell said: 'This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most.' The £11m funding for the trial was brought by the National Institute for Health and Care Research (NIHR) as UK Health and Social Care Secretary Wes Streeting plans to launch a National Cancer Plan and a call for evidence later today (4 January). Streeting said: 'As a cancer survivor, I feel like one of the lucky ones. That's why for World Cancer Day, I am committed to publishing a dedicated National Cancer Plan this year, to unleash Britain's potential as a world leader in saving lives from this deadly disease and make the NHS fit for the future through our Plan for Change.' Whilst the UK is making efforts to improve its rates of cancer detection, in some regards it has fallen behind other contemporary nations when it comes to cancer detection rates or the number of oncology trials currently in progress. In his report published last September, Lord Ara Darzi concluded that the UK has appreciably higher cancer mortality rates than other countries. That same report additionally concluded that in 2024, more than 35,000 genomic tests were completed each month but only around 60% on time. The Department for Health and Social Care (DHSC) has not detailed which technologies or AI models will be used as part of the EDITH trial. Presently, the body estimates that there are approximately 2.1 million breast cancer screens carried out across the country every year. New research published by GlobalData ahead of World Cancer Day found that oncology trials dominate ongoing clinical trials worldwide. Of those trials, breast cancer ranks third for the number of active trials just behind trials investigating pain and solid tumours. GlobalData is the parent company of Clinical Trials Arena. "UK launches AI EDITH trial to catch breast cancer earlier" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
